+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Carbimazole Market by Indication (Graves' Disease, Toxic Multinodular Goiter), End users (Clinics, Hospitals), Distribution Channel - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5967888
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Carbimazole Market grew from USD 234.91 million in 2023 to USD 245.90 million in 2024. It is expected to continue growing at a CAGR of 4.81%, reaching USD 326.59 million by 2030.

Carbimazole functions by decreasing the production of these thyroid hormones, thereby alleviating symptoms associated with hyperthyroidism, including rapid heartbeat, excessive sweating, and unexplained weight loss. The rise in the global incidence rate of thyroid-related disorders, including hyperthyroidism, propels the need for effective treatment options such as carbimazole. Moreover, enhanced awareness about thyroid health and advancements in diagnostic approaches for accurate and early detection of thyroid disorders stimulate market growth. However, side effects and safety concerns associated with carbimazole, including agranulocytosis, a rare but serious reduction in white blood cell count, which may limit its usage. Nevertheless, research into genetic markers and individual response patterns to Carbimazole can lead to more personalized and effective treatment strategies, opening new avenues for market expansion.

Regional Insights

The carbimazole market in the Americas, particularly in North America, demonstrates a balanced growth trajectory. This is largely due to the well-established healthcare infrastructure and heightened awareness regarding thyroid disorders in countries including the United States and Canada. In South America, access to carbimazole varies by country, with healthcare policies and the economic landscape influencing availability and consumption patterns. Europe represents a significant market for carbimazole, attributed to a higher prevalence of thyroid disorders and robust healthcare systems in countries including the U.K., Germany, and France. The market here benefits from comprehensive healthcare coverage that facilitates access to medications like carbimazole. The Asia Pacific region witnesses a rapid expansion driven by increasing healthcare expenditures and rising awareness of thyroid disorders. Countries including China and India, with their vast populations, are pivotal to this growth, harboring a substantial number of individuals affected by thyroid issues. Government initiatives aimed at improving healthcare infrastructure, along with growing middle-class affluence, are facilitating better access to medications, including carbimazole.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Carbimazole Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Increasing prevalence of thyroid disorders
  • Enhanced awareness about thyroid health and advancements in diagnostic
  • Improved healthcare infrastructure and accessibility to medicinal treatments in emerging economies

Market Restraints

  • Availability of alternative treatment options for hyperthyroidism

Market Opportunities

  • Research into genetic markers and individual response patterns
  • Development of more efficient and patient-friendly Carbimazole formulations

Market Challenges

  • Side effects and safety concerns associated with carbimazole

Market Segmentation Analysis

  • Indication: Cruciality of carbimazole in the management of Graves' Disease to inhibit the synthesis of thyroid hormones
  • End users: Ideality of clinics to offer carbimazole prescriptions in hyperthyroidism treatment

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Carbimazole Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Carbimazole Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Upsher-Smith Launches Methimazole Tablets A Generic Solution for Thyroid Disorders

Upsher-Smith has introduced generic Methimazole Tablets in 5 mg and 10 mg dosages, designed as an alternative to King Pharmaceuticals' Tapazole. These tablets are clinically recommended for individuals diagnosed with Graves' disease exhibiting hyperthyroidism, or those with toxic multinodular goiter, especially when surgical or radioactive iodine treatments are not viable options. Additionally, Methimazole serves to alleviate the symptoms of hyperthyroidism, making it a preparatory treatment before undergoing thyroidectomy or radioactive iodine therapy.

Manx Healthcare Expands Generic Portfolio with Carbimazole Tablet Launch

Manx Healthcare proudly announces the expansion of its Generics portfolio with the introduction of Carbimazole Tablets in 5mg and 20mg dosages. Available in packs of 100 tablets, these new offerings align with the company's commitment to broadening its product range.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Carbimazole Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Carbimazole Market, highlighting leading vendors and their innovative profiles. These include DCM Pharma Pvt. Ltd., Devlife Corporatio, Diffzene Pharmaceuticals, HCX Pharmaceuticals LLP, Healthy Inc., Manx Healthcare, Morningside Healthcare Ltd., Naiom Healthcare Private Limited, Newlife Medicare Private Limited, Omicron Pharma Private Limited, Psychocare Health Private Limited, and Steris Healthcare Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Carbimazole Market to forecast the revenues and analyze trends in each of the following sub-markets:

Indication

  • Graves' Disease
  • Toxic Multinodular Goiter

End users

  • Clinics
  • Hospitals

Distribution Channel

  • Online Pharmacies
  • Retail Pharmacies

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of thyroid disorders
5.1.1.2. Enhanced awareness about thyroid health and advancements in diagnostic
5.1.1.3. Improved healthcare infrastructure and accessibility to medicinal treatments in emerging economies
5.1.2. Restraints
5.1.2.1. Availability of alternative treatment options for hyperthyroidism
5.1.3. Opportunities
5.1.3.1. Research into genetic markers and individual response patterns
5.1.3.2. Development of more efficient and patient-friendly Carbimazole formulations
5.1.4. Challenges
5.1.4.1. Side effects and safety concerns associated with carbimazole
5.2. Market Segmentation Analysis
5.2.1. Indication: Cruciality of carbimazole in the management of Graves' Disease to inhibit the synthesis of thyroid hormones
5.2.2. End users: Ideality of clinics to offer carbimazole prescriptions in hyperthyroidism treatment
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Carbimazole Market, by Indication
6.1. Introduction
6.2. Graves' Disease
6.3. Toxic Multinodular Goiter
7. Carbimazole Market, by End users
7.1. Introduction
7.2. Clinics
7.3. Hospitals
8. Carbimazole Market, by Distribution Channel
8.1. Introduction
8.2. Online Pharmacies
8.3. Retail Pharmacies
9. Americas Carbimazole Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Carbimazole Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Carbimazole Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Upsher-Smith Launches Methimazole Tablets A Generic Solution for Thyroid Disorders
12.3.2. Manx Healthcare Expands Generic Portfolio with Carbimazole Tablet Launch
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. CARBIMAZOLE MARKET RESEARCH PROCESS
FIGURE 2. CARBIMAZOLE MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CARBIMAZOLE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CARBIMAZOLE MARKET DYNAMICS
FIGURE 7. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. CARBIMAZOLE MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. CARBIMAZOLE MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CARBIMAZOLE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CARBIMAZOLE MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CARBIMAZOLE MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CARBIMAZOLE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CARBIMAZOLE MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CARBIMAZOLE MARKET SIZE, BY GRAVES' DISEASE, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CARBIMAZOLE MARKET SIZE, BY TOXIC MULTINODULAR GOITER, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CARBIMAZOLE MARKET SIZE, BY TOXIC MULTINODULAR GOITER, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CARBIMAZOLE MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CARBIMAZOLE MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CARBIMAZOLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CARBIMAZOLE MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CARBIMAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CARBIMAZOLE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CARBIMAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CARBIMAZOLE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. AMERICAS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 26. AMERICAS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 27. AMERICAS CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 28. AMERICAS CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 29. AMERICAS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 30. AMERICAS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 33. ARGENTINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 34. ARGENTINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 35. ARGENTINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 36. ARGENTINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 37. ARGENTINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 38. ARGENTINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 39. BRAZIL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 40. BRAZIL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 41. BRAZIL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 42. BRAZIL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 43. BRAZIL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 44. BRAZIL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 45. CANADA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 46. CANADA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 47. CANADA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 48. CANADA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 49. CANADA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 50. CANADA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 51. MEXICO CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 52. MEXICO CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 53. MEXICO CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 54. MEXICO CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 55. MEXICO CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 56. MEXICO CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 57. UNITED STATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. UNITED STATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. UNITED STATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 60. UNITED STATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 61. UNITED STATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 62. UNITED STATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES CARBIMAZOLE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 66. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 67. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 68. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 69. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 70. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 73. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 74. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 75. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 76. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 77. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 78. AUSTRALIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 79. CHINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 80. CHINA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 81. CHINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 82. CHINA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 83. CHINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 84. CHINA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 85. INDIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 86. INDIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 87. INDIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 88. INDIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 89. INDIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 90. INDIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 91. INDONESIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 92. INDONESIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 93. INDONESIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 94. INDONESIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 95. INDONESIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 96. INDONESIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 97. JAPAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. JAPAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. JAPAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 100. JAPAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 101. JAPAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 102. JAPAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 103. MALAYSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. MALAYSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. MALAYSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 106. MALAYSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 107. MALAYSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 108. MALAYSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 109. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 112. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 113. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 114. PHILIPPINES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 115. SINGAPORE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 116. SINGAPORE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 117. SINGAPORE CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 118. SINGAPORE CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 119. SINGAPORE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 120. SINGAPORE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 121. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 124. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 125. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 126. SOUTH KOREA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 127. TAIWAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 128. TAIWAN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 129. TAIWAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 130. TAIWAN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 131. TAIWAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 132. TAIWAN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 133. THAILAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. THAILAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. THAILAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 136. THAILAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 137. THAILAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 138. THAILAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 139. VIETNAM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. VIETNAM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. VIETNAM CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 142. VIETNAM CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 143. VIETNAM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 144. VIETNAM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA CARBIMAZOLE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 153. DENMARK CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 154. DENMARK CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 155. DENMARK CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 156. DENMARK CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 157. DENMARK CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 158. DENMARK CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 159. EGYPT CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 160. EGYPT CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 161. EGYPT CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 162. EGYPT CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 163. EGYPT CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 164. EGYPT CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 165. FINLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 166. FINLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 167. FINLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 168. FINLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 169. FINLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 170. FINLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 171. FRANCE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 172. FRANCE CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 173. FRANCE CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 174. FRANCE CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 175. FRANCE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 176. FRANCE CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 177. GERMANY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. GERMANY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. GERMANY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 180. GERMANY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 181. GERMANY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 182. GERMANY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 183. ISRAEL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. ISRAEL CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. ISRAEL CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 186. ISRAEL CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 187. ISRAEL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 188. ISRAEL CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 189. ITALY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. ITALY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. ITALY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 192. ITALY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 193. ITALY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 194. ITALY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 195. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 196. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 197. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 198. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 199. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 200. NETHERLANDS CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 201. NIGERIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 202. NIGERIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 203. NIGERIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 204. NIGERIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 205. NIGERIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 206. NIGERIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 207. NORWAY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 208. NORWAY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 209. NORWAY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 210. NORWAY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 211. NORWAY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 212. NORWAY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 213. POLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. POLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. POLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 216. POLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 217. POLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 218. POLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 219. QATAR CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. QATAR CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. QATAR CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 222. QATAR CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 223. QATAR CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 224. QATAR CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 225. RUSSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 226. RUSSIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 227. RUSSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 228. RUSSIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 229. RUSSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 230. RUSSIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 232. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 234. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 236. SAUDI ARABIA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 237. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 238. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 239. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 240. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 241. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 242. SOUTH AFRICA CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 243. SPAIN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. SPAIN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. SPAIN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 246. SPAIN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 247. SPAIN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 248. SPAIN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 249. SWEDEN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 250. SWEDEN CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 251. SWEDEN CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 252. SWEDEN CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 253. SWEDEN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 254. SWEDEN CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 255. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 258. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 259. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 260. SWITZERLAND CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 261. TURKEY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 262. TURKEY CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 263. TURKEY CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 264. TURKEY CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 265. TURKEY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 266. TURKEY CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 274. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
TABLE 276. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
TABLE 278. UNITED KINGDOM CARBIMAZOLE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
TABLE 279. CARBIMAZOLE MARKET SHARE, BY KEY PLAYER, 2023
TABLE 280. CARBIMAZOLE MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • DCM Pharma Pvt. Ltd.
  • Devlife Corporatio
  • Diffzene Pharmaceuticals
  • HCX Pharmaceuticals LLP
  • Healthy Inc.
  • Manx Healthcare
  • Morningside Healthcare Ltd.
  • Naiom Healthcare Private Limited
  • Newlife Medicare Private Limited
  • Omicron Pharma Private Limited
  • Psychocare Health Private Limited
  • Steris Healthcare Pvt. Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages182
PublishedJune 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 245.9 Million
Forecasted Market Value ( USD ) by 2030 $ 326.59 Million
Compound Annual Growth Rate4.8%
Regions CoveredGlobal

Related Topics

Related Reports

Carbimazole (CAS 22232-54-8) Global Market Research Report 2024 - Product Image

Carbimazole (CAS 22232-54-8) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Global Congenital Hyperinsulinism Treatment Market by Indication Type, Treatment, Route of Administration, Distribution Channel, End-Users - Forecast 2024-2030 - Product Image

Global Congenital Hyperinsulinism Treatment Market by Indication Type, Treatment, Route of Administration, Distribution Channel, End-Users - Forecast 2024-2030

  • Report
  • 181 Pages
  • Global
From
Global Testosterone Replacement Therapy Market by Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism), Product Type (Buccal Adhesive, Gel or Creams, Implants), Drug Active Ingredient, Distribution Channel, End-Users - Forecast 2024-2030 - Product Image

Global Testosterone Replacement Therapy Market by Indication (Autoimmune Conditions, Genetic Disorders, Hypogonadism), Product Type (Buccal Adhesive, Gel or Creams, Implants), Drug Active Ingredient, Distribution Channel, End-Users - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Thyroid Gland Disorder Treatment Market Size, Share & Trends Analysis Report By Indication (Hypothyroidism), By Drug (Levothyroxine), By Distribution Channel, By Route of Administration, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 100 Pages
  • Global
From
Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029) - Product Image

Global Incretin Based Drugs Market (2023 Edition): Analysis By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors), Route of Administration, By Indication, By Region, By Country: Market Insights and Forecast (2019-2029)

  • Report
  • 230 Pages
  • Global
From

About the Carbimazole Market

Carbimazole is a drug used to treat endocrine and metabolic disorders. It is an antithyroid drug, meaning it works to reduce the production of thyroid hormones. It is used to treat hyperthyroidism, a condition in which the thyroid gland produces too much of the hormone thyroxine. It is also used to treat Graves' disease, an autoimmune disorder that causes the thyroid gland to produce too much thyroxine. Carbimazole is usually taken orally, but can also be administered intravenously. Common side effects include nausea, vomiting, and headache. The Carbimazole market is a niche market, with a limited number of manufacturers. Major players in the market include GlaxoSmithKline, Merck, Pfizer, and Sanofi. Other companies in the market include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.